Skip to content
AwardedCzechiaGoodsCZK 252,000,000

Genomické testy karcinomu prsu [2026–2030]

Published
Published 5 March 2026
Deadline
Closed 6 April 2026

Overview

Masarykův onkologický ústav has procured genomic breast cancer tests for the period 2026–2030 in accordance with specified technical and commercial terms. LERAM diagnostic s.r.o. was awarded the contract on 15 May 2026 for the full estimated value of 252 million CZK.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 252,000,000
Procedure
Open
Published
5 March 2026
Deadline
Closed
Classification (CPV)
Medical consumables

Award outcome

Awarded value
CZK 252,000,000
Award date
15 May 2026
Contract period
19 May 2026 → 9 May 2030
Winner
  • LERAM diagnostic s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    27 May 2026

  2. Contract Notice

    5 March 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Genomické testy karcinomu prsu [2026–2030] — won by LERAM diagnostic s.r.o. — Skim